Vancouver, British Columbia--(ACN Newswire via SeaPRwire.com - February 4, 2026) - Military Metals Corp. (CSE: MILI) (OTCQB: MILIF) (FSE: QN90) (the "Company" or "MILI") is pleased to report the additional analytical results of the Company's definition drilling campaign at the 100% owned flagship Trojárová Antimony-Gold Project (the "Project") in Slovakia as announced on November 4, 2025. The 2025 drilling campaign was designed to confirm historical drilling results and to support SLR Consulting's work towards establishing a current mineral resource estimate on the Project, which the company anticipates delivery of by the end of Q1, 2026, further discussed in the Company's January 9, 2025 announcement.These priority assay results represent the main mineralized zone from the third hole of the program, 25-TVA-003.Highlights of the Results from hole 25-TVA-003 Include:23.5 drilled (m) of 3.3 g/t Gold over a true width of 20.2m from 148.9m to 172.4mIncluding: 4.0m of 10.52 g/t Au over a true width of 3.4m from 157.9m to 161.9m1.9m of 2.53% Antimony over a true width of 1.6m from 169.9m to 171.8mScott Eldridge, Chief Executive Officer of the Company, commented, "We are thrilled with the second tranche of assays as we continue to see antimony grades that are consistent with historical results and higher than anticipated gold grades within the Trojárová Deposit. These strong gold results present the Company with new exploration opportunities that we are excited to evaluate. Trojárová represents the only antimony deposit in the European Union being advanced by modern mineral exploration and demonstrates characteristics that place it among the leading antimony projects globally. At a time when the need for secure, domestically sourced critical minerals is more pressing than ever, these results strengthen the project's potential importance to, and alignment with, the EU's objective of building a dependable, home-grown supply of essential raw materials."The Company additionally announces that logging and sampling of all drill core from the program is complete and all samples have successfully been delivered to ALS Laboratories in Roșia Montană, Romania for analysis. Additional results for all holes are pending.Table 1. Complete table of analytical results discussed in this release. Results exceeding 1.0 % Sb or 1.0 g/t Au are highlighted in red.Hole IDFrom (m)To (m)Drilledlength (m)True Width (m)Sample IDAntimony %Gold g/t25-TVA-003145.55146.50.950.813256260.016 0.01 146.5147.10.60.513256270.093 0.04 147.1148.110.863256280.123 0.52 148.1148.90.80.693256290.116 0.38 148.9149.910.863256311.145 1.1220.15m @ 3.3g/t True Width 149.9150.910.863256320.244 0.75 150.9151.910.863256330.057 0.7 151.9152.910.863256340.057 3.74 152.9153.910.863256360.279 4.5 153.9154.910.863256370.031 0.81 154.9155.910.863256380.189 1.05 155.9156.910.863256390.96 1.62 156.9157.910.863256410.807 1.3 157.9158.910.863256420.522 18.653.43m @ 10.52 g/tTrue Width158.9159.910.863256430.098 3.93159.9160.910.863256440.148 13.1160.9161.910.863256450.046 6.38161.9162.910.863256460.091 1.47 162.9163.910.863256470.169 0.76 163.9164.910.863256480.116 4.72 164.9165.910.863256490.088 1.76 165.9166.910.863256510.656 1.31 166.9167.910.863256520.307 1.37 167.9168.910.863256530.107 1.38 168.9169.910.863256540.247 1.19 169.9170.80.90.773256553.641.63m @ 2.53% True Width2.87 170.8171.810.863256561.542.66 171.8172.40.60.513256570.163 1.04 172.4173.410.863256580.136 0.08 173.4174.20.80.693256590.021 0.01 174.21750.80.693256610.582 0.35 17517610.863256621.57 0.71 17617710.863256630.097 2.01 177177.250.250.213256640.034 0.04 177.251780.750.643256660.507 0.34 17817910.863256670.103 0.24 17918010.863256680.261 0.62 18018110.863256690.1 0.54 181181.50.50.433256710.183 0.24 181.5182.510.863256720.018 0.01 182.5183.510.863256730.006 0.01 Figure 1. Gold mineralized drill core from hole 25-TVA-003 - 156.86m - 162.65m. Interval 157.9m to 161.9m yielded a composite grade of 10.52 g/t Au.To view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/10818/282604_8fb84a54641daa6e_002full.jpgFigure 2. Map of 2025 and Soviet era diamond drillholes in the north-central portion of Military Metals Trojárová Project.To view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/10818/282604_8fb84a54641daa6e_003full.jpgTable 2. Drillhole collar information for the Company's 2025 diamond drilling campaign at Trojárová. Locations presented are final and determined by a professional and qualified surveyor. WGS 84 / UTM Zone 33N DrillholeEastingNorthingElevation (m)Length (m)DipAzimuth25-TVA-0016626965358601640292.2-6522025-TVA-0026626855358668655289.7-7522025-TVA-0036625515358701634200.2-6522525-TVA-0046624755358809604256.5-5522525-TVA-0056623945358812580196-6023025-TVA-006662211535879556962.4-5722025-TVA-007662170535885255986.5-60210 Analytical and QA/QC ProceduresThe program was completed using PQ and HQ sized drill core. Sampled intervals were identified by logging geologists and assigned a unique sample identification number. Samples were split in two halves using a diamond bladed saw with one half remaining in the core box as a permanent record and the half placed in a plastic sample bag, both marked with a waterproof tag bearing the unique sample number which was also written on the sample bag in permanent marker. Samples were transported from the Company's secure facility by private courier to ALS Laboratories in Romania for geochemical analysis. ALS Laboratories is an independent ISO/IEC 17025:2017 and ISO 9001:2015 certified commercial laboratory with no relationship to the Company. The samples were analyzed using multi-element package ME_ICP41a and for gold using fire assay package Au-AA25. ME_ICP41a is an ore grade package involving digestion of a 0.4g sample by aqua regia with an Inductively coupled plasma - atomic emission spectrometry (ICP-AES) finish. The Au-AA25 fire assay method is an ore grade analysis using a 30g aliquot. The aliquot is mixed with flux composed of PbO and SiO2 with variable amounts of borax, soda ash and other reagents. The flux and sample are mixed, then heated at high temperature (>1,000°C) to decompose rock lattices and allow gold within the sample to be collected into a lead button. The button is placed in a porous cupel and heated again in an oxidizing environment to convert lead to lead oxide that is absorbed into the cupel, leaving the precious metals behind as a doré bead or prill. The gold content of the prill is then determined by atomic adsorption spectrometry.Both analyses are preceded by the preparation package Prep-31Y whereby the entire sample is crushed to 70% passing 2mm, a 250g split is collected by rotary splitter and pulverized to 85% passing 75 microns. Laboratory over-limits analysis methods were applied as required for both Sb and Au. A systematic QAQC protocol was employed that includes systematic insertion in the sample stream of certified reference materials and blank samples at a frequency of 1 in 10, plus analysis of duplicate pulp splits at a frequency of 1 in 30.About the Project and Historical ResourceDiscovered in the late 1970s, Trojárová was the focus of extensive surface and underground exploration over a 2km strike length from 1983 to 1995, with 63 core holes for a total of 14,330m, and 1.7km of underground workings completed. Efforts continued over the years as additional trenches were dug, and holes were drilled. Starting in 1990, underground development work began ultimately comprising a 300-meter-long adit connected to a 700-plus meter-long drive in the footwall of the mineralized zone with seven crosscuts into the mineralized zone for sampling purposes.These efforts culminated in a comprehensive study comprising drill logs, analyses, drill plans, maps and sections, deposit model studies, petrographic studies, metallurgical studies and more, now detailed in a multi-volume compendium of reports produced by the Slovak Geological Institute published in 1992, including a historical mineral resource estimate (see "Historical Resource Estimates" below). Per this historical estimate, at a cut-off grade of 1.0% antimony, Trojárová hosts 2.46 million tonnes averaging 2.47% antimony and 0.635 grams per tonne gold in a mineralized zone averaging 3.32 meters wide, containing approximately 60,000 tonnes of antimony in situ.Historical Resource EstimatesThe historical estimate related to the Trojárová Property was taken from a compendium produced by the Slovak Geological Survey, completed in March 1992 based on exploration work undertaking in the 1980s and 1990s. It is entitled (English translation): "FINAL JOB REPORT, PEZINOK-TROJAROVA, Geological Survey State Enterprise", report compendium number 78406 (Michel et al, 1992).The Slovak Geological Institute, the state agency that carried out all exploration and underground development work at Trojárová, classified the historical resources as "P1" and "C2" in the Slovak version of the Russian classification system, respectively. These are closest within the Canadian Institute of Mining, Metallurgy & Petroleum's ("CIM") classification system to "inferred mineral resources," which is defined by the CIM as that part of a mineral resource for which quantity and grade or quality are estimated on the basis of limited geological evidence gathered through appropriate sampling techniques from locations such as outcrops, trenches, pits, workings and drill holes.The historical work carried out appears comprehensive, detailed and at a professional standard. The Company considers this historical data to be relevant as the Company will use these data as a guide to plan future exploration programs. The Company also considers the data to be reliable for these purposes. A qualified person has not done sufficient work to classify the historical estimate as current, and the Company is not treating the historical estimate as current.Qualified PersonThe technical contents of this release were reviewed and approved by David Murray, P.Geo, VP-Exploration for Military Metals and a qualified person as defined by National Instrument 43-101.For more information about Military Metals Corp. and its critical minerals initiatives, please visit: https://www.militarymetalscorp.com.LinkedIn: https://www.linkedin.com/company/military-metals/X: https://x.com/militarymetalsFacebook: https://www.facebook.com/profile.php?id=61564717587797About Military Metals Corp. The Company is a British Columbia-based mineral exploration company that is primarily engaged in the acquisition, exploration and development of mineral properties with a focus on antimony.ON BEHALF OF THE BOARD of DIRECTORSFor more information, please contact:Scott EldridgeCEO and Directorscott@militarymetalscorp.com or info@militarymetalscorp.comFor enquiries, please call 604-537-7556Forward-Looking StatementsThis news release contains "forward-looking information". Often, but not always, forward-looking statements can be identified by the use of words such as "plans", "expects", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates", or "believes" or variations (including negative variations) of such words and phrases, or state that certain actions, events or results "may", "could", "would", "might" or "will" be taken, occur or be achieved. Forward-looking information in this news release includes the timing of the mineral resource estimate being currently conducted, and its completion at all, future drilling and exploration work at Trojárová, the continuation of the value of antimony, and the future needs of Europe and the E.U. specifically. A variety of factors, including known and unknown risks, many of which are beyond our control, could cause actual results to differ materially from the forward-looking information in this news release. These include geopolitical developments related to the supply and value of antimony, the continued use of antimony and availability of alternatives, availability of capital and labour in respect of the property that is the subject of this news release, the results of any future exploration activities, which cannot be guaranteed, and any other future activities in respect of the property held by the Target. Additional risk factors can also be found in the Company's public filings under the Company's SEDAR+ profile at www.sedarplus.ca. Forward-looking statements contained herein are made as of the date of this news release and the Company disclaims any obligation to update any forward-looking statements, whether as a result of new information, future events or results or otherwise. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. The Company undertakes no obligation to update forward looking statements if circumstances, management's estimates or opinions should change, except as required by securities legislation. Accordingly, the reader is cautioned not to place undue reliance on forward-looking statements.The Canadian Securities Exchange has neither approved nor disapproved the information contained herein and does not accept responsibility for the adequacy or accuracy of this news release.To view the source version of this press release, please visit https://www.newsfilecorp.com/release/282604 Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
BRUSSELS, BELGIUM, Feb 4, 2026 - (ACN Newswire via SeaPRwire.com) - Airwheel recently announced the continued rollout of its AI-driven rideable smart cabin suitcase solutions, marking a new phase in the evolution of intelligent travel mobility as global demand for smart transportation accelerates. Today, Airwheel’s sales and distribution network spans 68 countries and more than 4,600 retail locations worldwide. As its global expansion continues, the company’s electric and smart suitcases are transitioning from innovative products into high-frequency travel tools used by consumers around the world.Looking ahead, Airwheel will continue to advance the evolution of rideable smart luggage across technology, user experience, and application scenarios, allowing intelligent systems to integrate into travel in a more natural and intuitive way—so that travel becomes not just a means of transportation, but an opportunity to explore the world and enjoy life.As smart mobility continues to reshape global travel and transportation, intellectual property and design capability have emerged as key factors distinguishing true industry leaders from short-term innovators. In the field of rideable suitcase and smart mobility solutions, Airwheel has steadily strengthened its leadership position through long-term, systematic investment in technology and design.As one of the pioneers of the rideable smart luggage category, Airwheel has built a clear and robust competitive moat at the core technology level. To date, the company has accumulated more than 600 patents worldwide, covering critical areas such as motion control algorithms, electric drive systems, intelligent sensing, and structural design, including multiple international invention patents. In parallel, Airwheel has advanced its global intellectual property strategy, with trademarks registered in more than 168 countries and regions, providing a solid foundation for regulatory compliance, large-scale commercialization, and long-term brand development across international markets.Amid the rapid iteration of smart mobility products, design capability has become an equally important measure of product maturity. If patents represent technological depth and engineering strength, then international design awards serve as authoritative recognition of product philosophy, user experience, and comprehensive design excellence. In recent years, multiple Airwheel smart products have received recognition from leading global design awards, including the German iF Design Award, the U.S. IDEA Awards, the IAI Design Award, and the Berlin Design Award, demonstrating the brand’s consistent and high-level design output in the smart mobility space.These awards go far beyond aesthetics, evaluating products across dimensions such as usability logic, safety architecture, engineering integrity, human–machine interaction, and future application potential. Recognition from such professional juries indicates that Airwheel’s smart suitcase designs have been rigorously validated for both functional completeness and real-world usability, further enhancing the brand’s credibility in global markets.At the product level, the global popularity of the Airwheel SE3S Series marks a significant milestone in bringing rideable smart luggage into the mainstream. True product maturity is not defined solely by technical completeness, but by its ability to enter popular culture and everyday consumer awareness. Driven by social media and short-form video platforms, the Airwheel SE3S Series has become a favored electric suitcase among international celebrities, content creators, and fashion-forward travelers—often described as both a mobility tool and a “mobile lifestyle accessory.”Frequently seen in airports, fashion events, street photography, and travel scenarios, this rideable smart cabin suitcase not only serves a functional purpose but also delivers emotional value and personal expression. According to public data and platform analytics, content related to the Airwheel SE3S Series has generated tens of billions of impressions globally, transcending the boundaries of a single product category and becoming widely recognized as a fashionable travel symbol in the digital era.User feedback has further reinforced this dual identity. Many consumers describe the SE3S Series as “instantly recognizable” and “a travel companion that makes journeys lighter and more enjoyable,” strengthening its positioning at the intersection of smart mobility and lifestyle consumption.Notably, Airwheel has expanded its smart luggage ecosystem beyond adult users. The company also offers the SQ3 Series, a rideable smart suitcase designed specifically for children. By prioritizing safety and structural stability, the SQ3 Series introduces greater interaction and enjoyment into family travel, positioning smart luggage as an integral part of the parent-child travel experience.From a compliance perspective, the Airwheel SE3S Series is designed as a cabin suitcase, featuring a detachable lithium battery that meets airline safety standards, allowing it to be carried onboard flights in accordance with major international airline regulations. This design enables frequent, legal, and reliable use in airport environments worldwide, making it a practical choice for international travelers.Evolving from a mobility device into a source of emotional value and, ultimately, a widely recognized fashion travel product, the rise of the Airwheel SE3S Series signals that rideable smart luggage is becoming a natural part of everyday global travel.About AirwheelFounded in 2004, Airwheel is a global smart transportation device manufacturer with R&D, marketing, manufacturing, and logistics centers in the United States, Belgium, and China. The company has integrated the portable transportation industrial chain and built a globally recognized brand, serving more than 30 million users across 68 countries. Guided by its philosophy of “Free Intelligent Life,” Airwheel leverages technologies such as IoT sensors, robotics, and deep learning to develop intelligent mobility solutions that enhance freedom, joy, and everyday travel experiences worldwide.Media ContactCompany: AirwheelContact: Media TeamWebsite: https://www.airwheel.net Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
ROMEOVILLE, IL, Feb 2, 2026 - (ACN Newswire via SeaPRwire.com) - Formerra, a leader in performance materials distribution, today announced an expanded distribution agreement that brings Evonik's CARE brand healthcare grades into Formerra's medical portfolio. Covering the United States and Canada, the agreement creates new access points for high-performance polyamides used in essential healthcare applications.This expansion kicks off at MD&M West 2026 this week, and underscores both companies' commitment to supporting the healthcare market with high-performance materials, responsive service, and continuity of supply. It also builds on the companies' two-year partnership, which introduced Evonik's VESTAMID® and TROGAMID® families to Formerra's engineered materials lineup.With this expansion, Formerra will support Evonik healthcare grades designed for fluid handling, drug delivery, diagnostic systems, surgical instrument parts, medical device housings, components that see short-term body contact (< 30 days), and other non-implantable applications requiring strength, clarity, chemical resistance, and consistent processing.Key medical grade materials include:VESTAMID® Care ML PA12VESTAMID® Care ME PEBA elastomerTROGAMID® Care MX microcrystalline PA"Our healthcare customers rely on stable supply, world-class regulatory support, and materials that perform under demanding conditions," said Steve Harmon, Director, Key Accounts, Formerra. "Evonik's healthcare grades bring the combination of durability, processing consistency, and documentation support that medical manufacturers require. This expansion lets us strengthen the technical resources and materials pipeline available to teams developing next-generation devices.""Formerra's ability to serve the whole supply chain in the medical space, from design companies to compounders to medical device OEMs, with technical rigor and exceptional logistics and with already-proven successful demonstration in the industrial space, made this expansion with CARE brand Polyamide 12 products a natural step," said Basker Lalgudi, Business Manager, Global Medical Devices, Evonik. "Their healthcare expertise and focus help customers select and implement our materials with confidence across a range of critical applications."By adding Evonik's healthcare CARE brand materials, Formerra will offer customers a proven set of polyamide solutions that support regulatory pathways, design requirements, and long-term reliability. Formerra's team will provide material selection guidance, processing support, and regional supply chain readiness to help OEMs and molders accelerate development cycles.Formerra will exhibit at MD&M West in Booth 2266 in Anaheim, California, Feb. 3-5, 2026.Key Details:Formerra will distribute Evonik's CARE brand healthcare grades across the U.S. and Canada.Materials include healthcare grades within the VESTAMID® L, VESTAMID® E, and TROGAMID® CX families, plus designated sustainable options.The agreement strengthens Formerra's medical portfolio and expands its support for fluid management, diagnostics, wearables, and device housings.Formerra will provide application guidance, regulatory documentation support, and supply chain continuity for medical customers.About FormerraFormerra is a preeminent distributor of engineered materials, connecting the world's leading polymer producers with thousands of OEMs and brand owners across healthcare, consumer, industrial, and mobility markets. Powered by technical and commercial expertise, it brings a distinctive combination of portfolio depth, supply chain strength, industry knowledge, service, leading e-commerce capabilities, and ingenuity. The experienced Formerra team helps customers across multiple industries to design, select, process, and develop products in new and better ways, driving improved performance, productivity, reliability, and sustainability. To learn more, visit www.formerra.com.About EvonikEvonik goes beyond the boundaries of chemistry with its combination of innovative strength and leading technological expertise. The global chemical company, headquartered in Essen, Germany, is active in more than 100 countries and generated sales of €15.2 billion and earnings (adjusted EBITDA) of €2.1 billion in 2024. The common motivation of the approximately 32,000 employees: to provide customers with a decisive competitive advantage with tailor-made products and solutions as a superforce for industry, thereby improving people's lives. In all markets. Every day. To learn more, visit www.evonik.com.Media ContactJackie MorrisMarketing Communications Manager, Formerrajackie.morris@formerra.com+1 630-972-3144SOURCE: Formerra Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
Vancouver, British Columbia--(ACN Newswire via SeaPRwire.com - February 3, 2026) - Casa Minerals Inc. (TSXV: CASA) (OTCQB: CASXF) (FSE: 0CM) (the "Company" or "Casa"), is pleased to announce the closing of the first tranche of its previously announced non-brokered private placement (the "Offering"). The Company has closed on a total of 4,917,000 units (each, a "Unit") at a price of $0.125 per unit for gross proceeds of up to $614,625.00.Each Unit consists of one common share of the Company (a "Share") and one common share purchase warrant (each full warrant, a "Warrant"). Each of the 4,917,000 Warrants entitles the holder to acquire one additional share for a period of two years until February 04, 2028. The warrant exercise strike price is $0.15/share in the first three months and automatically converts to $0.20 per share then after for the remainder of the two years period.All issued Securities will be subject to a 4-month and one day hold-period, during which any resale or other transfer will be restricted in accordance with applicable securities laws.A Finder's Fees of $24,000 has been paid to registered financial institutions.Net proceeds from the offering will be used for general administration, exploration and development activities on the Company's projects in Arizona, and British Columbia, Canada. The Company will continue to raise the remaining placement in the coming week.The completion of the private placement remains subject to approval of the TSX Venture Exchange.None of the securities issued in the Offering will be registered under the United States Securities Act of 1933, as amended (the "1933 Act"), and none of them may be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the 1933 Act.About Casa Minerals Inc.The Company is engaged in the acquisition, exploration and development of mineral properties located in Canada and the USA. Casa owns ninety percent (90%) interest in the Congress gold mine (Arizona, USA). Additionally, the Company owns a one hundred percent (100%) interest in the polymetallic Pitman (BC, Canada) and has an option to acquire a seventy-five percent (75%) interest in the Arsenault VMS Property (BC, Canada).On Behalf of Board of Directors,Farshad Shirvani, M.Sc. GeologyPresident and CEOFor more information, please contact:Casa Minerals Inc.Farshad Shirvani, President & CEOPhone: (604) 678-9587Email: contact@casaminerals.comhttps://www.casaminerals.comNEITHER TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.To view the source version of this press release, please visit https://www.newsfilecorp.com/release/282620 Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
伊利诺伊州罗密欧维尔市, 2026年2月2日 - (亚太商讯 via SeaPRwire.com) - 高性能材料分销领导者福美拉今日宣布达成扩展分销协议，将赢创CARE品牌医疗级产品纳入其医疗产品组合。该协议覆盖美国和加拿大市场，为关键医疗应用领域的高性能聚酰胺材料开辟了全新渠道。此次扩展将于本周在MD&M West 2026展会启动，彰显双方通过高性能材料、响应式服务及稳定供应支持医疗市场的承诺。此举亦基于两家公司两年的合作基础——此前已将赢创VESTAMID®和TROGAMID®系列引入Formerra工程材料产品线。通过此次扩展，福美来将支持赢创医疗级材料的应用领域，涵盖流体处理、药物输送、诊断系统、手术器械部件、医疗器械外壳、短期人体接触部件（<30天）及其他需兼具强度、透明度、耐化学性与稳定加工性能的非植入类应用。核心医疗级材料包括：VESTAMID® Care ML PA12VESTAMID® Care ME PEBA弹性体TROGAMID® Care MX微晶PA“医疗客户依赖稳定供应、世界级法规支持及严苛环境下的材料性能，”福美来关键客户总监Steve Harmon表示，“赢创医疗级材料兼具耐久性、加工一致性及文档支持，满足医疗制造商需求。此次扩展使我们能为开发新一代设备的团队提供更强大的技术资源与材料渠道。”“福美来凭借严谨的技术实力与卓越的物流体系，已成功在工业领域验证其服务能力，现可覆盖医疗全产业链——从设计公司到复合材料制造商再到医疗器械OEM厂商。此次引入CARE品牌聚酰胺12产品，正是顺理成章的战略拓展。”赢创全球医疗器械业务经理巴斯克·拉尔古迪强调，“其医疗专长与聚焦优势，助力客户在各类关键应用场景中自信选用并实施我们的材料方案。” “其医疗健康领域的专业知识和专注度，能帮助客户在各类关键应用中自信地选择并实施我们的材料。”通过引入赢创医疗健康CARE品牌材料，Formerra将为客户提供一套经过验证的聚酰胺解决方案，支持法规路径、设计要求及长期可靠性。Formerra团队将提供材料选型指导、加工支持及区域供应链保障，助力OEM厂商和注塑商加速开发周期。Formerra将于2026年2月3日至5日在加州阿纳海姆举办的MD&M West展会2266号展位亮相。核心要点：Formerra将在美国和加拿大分销赢创CARE品牌医疗级材料。涵盖VESTAMID® L、VESTAMID® E、TROGAMID® CX系列医疗级材料及指定可持续选项协议强化Formerra医疗产品组合，拓展其在流体管理、诊断设备、可穿戴设备及器械外壳领域的支持能力Formerra将为医疗客户提供应用指导、法规文件支持及供应链持续性保障关于FormerraFormerra是工程材料领域的顶尖分销商，将全球领先的聚合物生产商与医疗、消费品、工业及移动设备市场的数千家OEM厂商和品牌所有者紧密连接。依托技术与商业专长，我们以独特的组合优势著称：产品组合深度、供应链实力、行业知识、专业服务、领先的电子商务能力及创新思维。经验丰富的Formerra团队助力多行业客户以创新方式设计、选材、加工和开发产品，持续提升性能、生产力、可靠性及可持续性。了解更多请访问www.formerra.com。关于赢创赢创凭借创新实力与领先技术专长，不断突破化学领域的边界。这家总部位于德国埃森的全球化工企业业务遍及100多个国家，2024年实现销售额152亿欧元，调整后息税折旧摊销前利润（EBITDA）达21亿欧元。约32,000名员工秉持共同使命：以量身定制的产品与解决方案成为工业领域的超级力量，为客户提供决定性竞争优势，从而改善人类生活。遍及所有市场。日日践行。了解更多请访问www.evonik.com。媒体联络杰基·莫里斯福美来市场传播经理jackie.morris@formerra.com+1 630-972-3144来源：福美来 Copyright 2026 亚太商讯 via SeaPRwire.com. All rights reserved. www.acnnewswire.com
MIAMI, FL, Feb 2, 2026 - (ACN Newswire via SeaPRwire.com) - Digi Power X Inc. ("Digipower X" or the "Company") (Nasdaq:DGXX)(TSXV:DGX), a vertically integrated AI infrastructure company focused on the deployment of Tier-3 modular data centers powered by owned and controlled energy assets, today announced that Hans Vestberg, former Chairman and Chief Executive Officer of Verizon Communications, has joined the Company as a senior advisor serving on its Advisory Board to support the Company's expansion strategy.Mr. Vestberg brings more than three decades of global leadership in mission-critical infrastructure, telecommunications networks, and large-scale capital deployment. He is widely recognized for leading Verizon's first commercial 5G deployment in 2018 and for advancing nationwide fiber, mobile edge computing, and next-generation network architectures.Prior to Verizon, Mr. Vestberg spent nearly three decades at Ericsson, including almost seven years as its Chief Executive Officer, where he helped build and operate global infrastructure facilitating approximately 35% of worldwide mobile traffic.Mr. Vestberg's appointment comes at a time when AI adoption is increasingly constrained, not by software or silicon, but by power availability, cooling capacity, and deployment speed. Digipower X is working on addressing this challenge through the deployment of the AI-Ready Modular Solution (ARMS) platform, designed to deliver Tier-3 modular AI data centers within approximately 180 days, supported by a vertically integrated power strategy and a growing portfolio of large-scale energy assets."Hans Vestberg built and scaled the physical infrastructure that helped enable the fiber, mobile, and 5G revolutions," said Michel Amar, Chairman and Chief Executive Officer of Digipower X. "He understands what most of the market overlooks: AI's bottleneck isn't algorithms or chips, it's power, cooling, and deployment speed. Hans knows how to execute infrastructure transformation at a national and global scale, and we expect his guidance will be invaluable as we expand our modular AI data center footprint.""I've spent over 30 years building the networks that move data," said Mr. Vestberg. "The next decade is about building the infrastructure that processes it. Digipower X is more than just a data center company. It controls its power, is developing the ability to deploy Tier-3 infrastructure in the near term, and is building a modular platform to address the exact constraints holding back large-scale AI deployment. Its focus on power availability and deployment speed first, real estate second, is exactly the right approach."Infrastructure Experience Aligned with AI ScaleDuring his tenure at Ericsson (2010-2016), Mr. Vestberg led more than 115,000 employees worldwide and positioned the company at the forefront of next-generation wireless technologies. At Verizon (2018-2025), he reshaped the organization around a network-first strategy, oversaw major investments in spectrum and fiber, and advanced distributed edge-compute capabilities to enable data-intensive and latency-sensitive applications.Mr. Vestberg insightfully noted at Davos 2024 that "one of the most important infrastructures of this century is digital infrastructure," and that AI workloads will increasingly migrate from centralized hyperscale facilities toward distributed locations supporting real-time inference and enterprise demand.Mr. Vestberg currently serves as a board member of BlackRock and Verizon.Addressing the Power and Deployment Constraint in AI InfrastructureDigipower X operates a combined-cycle power plant and three additional operating sites, with more than 200 megawatts of power currently online. The Company has secured development capacity to support AI infrastructure expansion over the next three years, with the ability to develop up to an additional 1.5 gigawatts of power capacity, including at major sites in North Carolina and West Virginia.In West Virginia, Digipower X has entered into a letter of intent relating to a 1.3-gigawatt power plant, which is being evaluated as a long-term site for AI data center and advanced computing infrastructure deployment."Hans recognizes that national AI competitiveness depends on solving power availability and deployment speed," said Gerard Rotonda, Board Member of Digipower X and former CFO of Deutsche Bank Wealth & Asset Management Americas. "His experience aligns directly with Digipower X's mission to deliver infrastructure at the scale and speed this market now requires."Vestberg's Strategic FocusIn his advisory role, Mr. Vestberg will work closely with Digipower X's executive team on:AI infrastructure deployment strategy and scaling frameworks;Distributed and edge-compute architectures for inference-driven workloads;Strategic partnerships with hyperscalers, enterprises, and infrastructure stakeholders;Power optimization and energy-efficient data center design;Tier-3 redundancy and mission-critical reliability standards; andInternational expansion strategy and site prioritization.About Digipower XDigipower X is an innovative energy infrastructure company that develops Tier III-certified modular AI data centers and drives the expansion of sustainable energy assets.For further information, please contact:Michel Amar, Chief Executive OfficerDigipower X Inc.www.digipowerx.comInvestor RelationsT: 888-474-9222Email: IR@digihostpower.comCautionary StatementTrading in the securities of the Company should be considered highly speculative. No stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein. Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.Forward-Looking StatementsExcept for the statements of historical fact, this news release contains "forward-looking information" and "forward-looking statements" (collectively, "forward-looking information") that are based on expectations, estimates and projections as at the date of this news release and are covered by safe harbors under Canadian and United States securities laws. Forward-looking information in this news release includes information about the Company's expectations concerning the potential contributions by our new advisor to the Company's strategic efforts, the potential further improvements to profitability and efficiency across the Company's operations, including, as a result of the Company's expansion efforts, potential for the Company's long-term growth and clean energy strategy, and the business goals and objectives of the Company. Factors that could cause actual results to differ materially from those described in such forward-looking information include, but are not limited to: delivery of equipment and implementation of systems may not occur on the timelines anticipated by the Company or at all; future capital needs and uncertainty of additional financing; share dilution resulting from equity issuances; risks relating to the strategy of maintaining and increasing Bitcoin holdings and the impact of depreciating Bitcoin prices on working capital; statements regarding the timing, scale and expansion of AI and high-performance computing infrastructure; changes in demand for AI and high-performance computing; future data center capacity may not be realized at the level anticipated by the Company, or at all; development of additional facilities and installation of infrastructure to expand operations may not be completed on the timelines anticipated by the Company, or at all; ability to access additional power from the local power grid; the Company may not be able to profitably liquidate its current digital currency inventory, or at all; a decline in digital currency prices may have a significant negative impact on the Company's operations; the volatility of digital currency prices; and other related risks as more fully set out in the Annual Information Form of the Company and other documents disclosed under the Company's filings at www.sedarplus.ca and www.SEC.gov/EDGAR. The forward-looking information in this news release reflects the current expectations, assumptions and/or beliefs of the Company based on information currently available to the Company. In connection with the forward-looking information contained in this news release, the Company has made assumptions about, among other things, profitable use of the Company's assets going forward; the demand for data center capacity for AI and high-performance computing; and there will be no regulation or law that will prevent the Company from operating its business. The Company has also assumed that no significant events occur outside of the Company's normal course of business. Although the Company believes that the assumptions inherent in the forward-looking information are reasonable, forward-looking information is not a guarantee of future performance and accordingly undue reliance should not be put on such information due to the inherent uncertainties therein. The Company undertakes no obligation to revise or update any forward-looking information other than as required by applicable law.SOURCE: Digi Power X Inc. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
NEEDHAM, MA, Feb 2, 2026 - (ACN Newswire via SeaPRwire.com) - Bioxytran, Inc. (OTCQB: BIXT) (“Bioxytran” or the “Company”), a clinical-stage biotechnology company developing platform technologies spanning glycovirology, hypoxia, and degenerative diseases, announced the execution of a Sponsored Research Agreement with the University of Minnesota to support advanced biochemical research aimed at improving the understanding and development of novel polysaccharide and oligosaccharide interactions with biologically relevant targets.Under the agreement, research will be conducted at the University of Minnesota under the direction of Dr. Kevin Mayo, a recognized expert in biomolecular structure and nuclear magnetic resonance spectroscopy The collaboration is designed to further characterize carbohydrate-binding interactions that may play a role in future therapeutic and diagnostic applications.“This collaboration with the University of Minnesota represents an important step in strengthening the scientific foundation behind our carbohydrate-based technology platform,” said David Platt, CEO of Bioxytran. “By leveraging the University’s deep expertise in structural biology and advanced nuclear magnetic resonance spectroscopy, we aim to generate high-quality data that supports the continued evolution of our research and development pipeline.”Research FocusThe sponsored research program will explore how specific polysaccharides and related carbohydrate structures interact with target molecules relevant to biological systems. Using state-of-the-art nuclear magnetic resonance methodologies, the research team will analyze binding interactions, structural conformations, and affinity characteristics of select carbohydrate compounds. The work is expected to build on Bioxytran’s existing research into carbohydrate-based materials and their potential applications across biomedical and life-science domains. Findings from the study may help guide future development strategies and inform additional preclinical research initiatives.Academic–Industry CollaborationThe agreement reflects a shared commitment to advancing scientific knowledge through collaboration between academia and industry. The University of Minnesota will carry out the research in accordance with its established academic standards, ensuring scientific rigor, transparency, and adherence to institutional research policies.This type of partnership exemplifies how academic research institutions and innovative companies can work together to address complex scientific questions,” said Dr. Kevin Mayo, Principal Investigator and Professor at the University of Minnesota. “Our goal is to apply advanced analytical tools to generate insights that are both scientifically meaningful and relevant to real-world applications.”Timeline and StructureThe research term is expected to run through early 2027, with defined milestones, periodic progress reviews, and structured reporting. Bioxytran will provide funding to support research personnel, nuclear magnetic resonance facility access, and associated laboratory resources required to execute the program. In accordance with standard sponsored research practices, the University of Minnesota will retain ownership of any intellectual property generated through the research, while Bioxytran will receive broad rights to use the resulting research data for internal research and development purposes.Strategic SignificanceFor Bioxytran, the collaboration supports a broader strategy focused on strengthening its scientific validation, expanding academic partnerships, and advancing next-generation carbohydrate technologies. The company believes that well-characterized molecular interactions are a critical step toward unlocking new therapeutic pathways and accelerating innovation.The University of Minnesota continues to be recognized globally for its leadership in biomedical research and technology transfer, making it an ideal partner for companies seeking to bridge fundamental science and commercial development.About the University of MinnesotaThe University of Minnesota is one of the nation’s leading public research universities, known for its commitment to discovery, innovation, and the translation of research into real-world impact. Through industry partnerships and sponsored research programs, the University fosters collaboration that advances science and benefits society.About Bioxytran, Inc.Bioxytran is a clinical-stage pharmaceutical company developing platform technologies in glycovirology, hypoxia and degenerative diseases using carbohydrate drug design, including programs that leverage galectin inhibition and programs that aim to address hypoxic conditions and tissue oxygenation. Bioxytran’s common stock trades on the OTCQB under the symbol BIXT.Company Contact:Bioxytran, Inc.75 Second Avenue, Needham, MA 02494Phone: 617‑454‑1199Email: info@Bioxytraninc.comWeb: www.Bioxytraninc.comForward-Looking StatementsThis press release contains forward-looking statements, including statements regarding anticipated regulatory interactions, future clinical trials, trial designs, timing of data submission and publication, and potential therapeutic and commercial opportunities. Forward-looking statements are based on current expectations and are subject to risks and uncertainties that could cause actual results to differ materially. Readers are urged to review the Company’s risk factors disclosed in its reports filed with the U.S. Securities and Exchange Commission, including its Annual Report on Form 10‑K for the year ended December 31, 2024. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
香港, 2026年2月2日 - (亚太商讯 via SeaPRwire.com) - 君圣泰医药（2511.HK），一家专注于开发多功能创新疗法、以解决代谢性慢病未满足临床需求的创新药公司今日宣布，任命Filip Surmont博士为首席医学官，全面负责公司的医学战略、临床开发及相关医学事务，助力公司核心管线在心肾代谢系统疾病（CKM）领域的研发进展与价值提升。Filip Surmont博士在医疗与制药行业拥有超过30年的丰富经验，其中包括18年在跨国药企担任领导职务，以及16年的临床实践经验。他在心血管、代谢和肾脏疾病领域是全球公认的行业领导者，曾任职于惠氏、辉瑞、阿斯利康等跨国药企，担任高级医学领导职务，并在新兴市场、拉丁美洲、欧美及中国等多个地区领导医学事务工作，在复杂的全球医疗体系中成功打造高绩效团队，并推动多项临床实践变革。Filip Surmont博士职业生涯成就卓著。他助力达格列净成为重磅畅销药物；也曾在中国主导"ACT on HF"项目，成功让20万名心衰患者受益于指南推荐的标准治疗；他首创的哮喘"抗炎缓解剂（AIR）"治疗策略，影响了全球约5000万名患者，并推动了国际治疗指南的更新。作为国际权威医学专家，Filip Surmont 博士长期深耕代谢及心血管相关疾病研究并积累了深厚学术声望，多项研究发表于《The Lancet Diabetes & Endocrinology》、《Journal of the American College of Cardiology》等顶级期刊。在职业生涯早期，Filip Surmont博士曾为奥运级运动员提供医疗服务。Filip Surmont博士拥有比利时根特大学医学博士学位及运动医学硕士学位。君圣泰医药创始人、董事长兼首席执行官刘利平博士表示："我们热忱欢迎Filip Surmont博士正式加入君圣泰医药并担任首席医学官。他在心血管、代谢和肾脏疾病领域拥有丰富的全球经验、卓越的医学领导力与业界认可的成功经验。我们相信Filip Surmont博士的加入，将进一步强化公司的医学与临床开发能力，助力公司核心管线在CKM领域的临床开发与全球合作，为公司下一阶段发展注入强大动力。"君圣泰医药首席医学官Filip Surmont博士表示："我很荣幸加入君圣泰医药。君圣泰医药在代谢性疾病领域的研发策略与管线布局，尤其是核心产品在CKM领域的临床潜力，与当前全球代谢慢病的未满足医疗需求高度契合。我期待与团队紧密合作，促进公司创新药物的价值转化，为全球CKM患者带来全新的治疗选择。"关于君圣泰医药君圣泰医药（股票代码：2511.HK）是一家专注于代谢性慢病的创新生物医药公司，旨在开发多功能、多靶点的创新疗法，重点聚焦于解决心肾代谢系统疾病(CKM)。立足源头创新，公司致力于开发突破性疗法，为全球患者提供标本兼治、综合获益的解决方案。公司已建立100%自主知识产权的全球化产品管线，在多个国家和地区开展了针对多项适应症的临床研究。公司核心产品HTD1801已获得美国食品药品监督管理局（FDA）2项快速通道与1项孤儿药资格认定、以及十三五"重大新药创制"国家科技重大专项。更多信息，请访问公司官网：www.hightidetx.com，或联系公司品牌部：pr@hightidetx.com Copyright 2026 亚太商讯 via SeaPRwire.com. All rights reserved. www.acnnewswire.com
HONG KONG, Feb 2, 2026 - (ACN Newswire via SeaPRwire.com) – On 30 January, COSMOPlat IoT Technology Co., Ltd. ("COSMOPlat" or the "Company") formally commenced its initial public offering (IPO) process in Hong Kong, positioning itself to become the first listed entity in the Hong Kong market focused on the "AI + Industrial Internet" sector. As a leading provider of industrial digitalization and intelligent products and solutions in China, COSMOPlat is dedicated to the deep integration of advanced technologies including Artificial Intelligence (AI), the Internet of Things (IoT), and big data with industrial applications, facilitating high-quality development within the manufacturing industry. The Company has established itself as one of the foremost players in the implementation of industrial solutions, having served over 160,000 enterprise clients to date, including more than 9,500 paying enterprise clients. The Company has successfully assisted clients in establishing 17 Lighthouse Factories.According to Frost & Sullivan, the Company ranked first in China's platform-based industrial data intelligence solutions market by revenue in 2024. Utilizing its proprietary industrial large model-driven COSMOPlat Industrial Internet Platform, the Company has developed a distinctive integrated edge-cloud product and service system, offering both Data Intelligence Solutions and IoT Solutions to its users.The Company has achieved deep integration of AI technology within industrial settings, developing industrial intelligent agents that cover more than 40 core scenarios across three major industries. The number of high-quality intelligent agents has now increased to 57. The Company's enterprise-level industrial internet platform product, COSMO-Sphere, employs a modular architecture. This allows enterprises to flexibly construct their digital infrastructure according to specific requirements, achieving high compatibility and cost-effective deployment.The Company has progressively developed an AI-driven flywheel that operates through four steps: data accumulation, model iteration, intelligent agent deployment and industrial value realization. Furthermore, it has built a comprehensive, full-stack AI technology system encompassing training and inference platforms, large models, and intelligent agent development and application platforms. This continuously strengthens the Company's technological leadership within the industrial digitalization and intelligence landscape. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
HONG KONG, Feb 2, 2026 - (ACN Newswire via SeaPRwire.com) – On 29 January, Muyuan Foods Co., Ltd. (“Muyuan Foods” or the “Company”, Stock Code: 2714.HK), a leading enterprise in China’s pork industry, officially launched its share offering. This marks a crucial implementation phase in the Company’s listing process on the Hong Kong Stock Exchange, and also accelerates the implementation of its strategic international layout.As a technology-driven leader in the pork industry, Muyuan Foods has consistently set the pace for the development of the smart hog farming industry. According to Frost & Sullivan, the Company has ranked as the world’s largest hog farming enterprise in terms of both hog production capacity and sales volume since 2021. It has ranked the first globally in terms of hog sales volume for four consecutive years, securing an unassailable leading position in the industry. The continuous growth in the Company’s market share further validates its core competitiveness. Measured by hog sales volume, the Company’s global market share rose steadily from 2.6% in 2021 to 5.6% in 2024. Its market share in 2024 alone exceeded the combined market share of the world’s second to fourth largest industry participants, establishing remarkable scale advantages and industrial influence.Strategic Expansion into Overseas Markets, Vertically-Integrated Business Model Driving Robust Performance GrowthOn the basis of consolidating its leading domestic position and strengthening its development foundation, Muyuan Foods has further formulated its global strategy and actively expanded into overseas markets. Taking the export of technologies and equipment as a core approach, the Company empowers the upgrading of the global hog farming industry and builds an internationalised farming ecosystem. In 2024, the Company entered into a strategic partnership with BAF Vietnam Agriculture Joint Stock Company, providing comprehensive services including hog house design, biosecurity management, odor control solutions and smart hog farming equipment, so as to optimize its hog farming efficiency and ensure environmentally responsible operations, marking a pivotal first step in the Company’s global expansion.Going forward, the Company will continue to replicate its well-proven domestic technology system and cost management expertise to overseas markets with high growth potential. Meanwhile, the Company will integrate high-quality global resources with a global perspective, achieving optimised resource allocation and efficient collaboration. This will further consolidate the Company’s core advantages, enhance its overall competitiveness, continuously expand the boundaries of corporate growth, and support the Company in achieving high-quality global development.In terms of business model, with over 30 years of profound expertise in the hog farming industry, Muyuan Foods has established a vertically-integrated business model covering the entire industrial chain, encompassing hog breeding, hog farming, feed production, as well as slaughtering and meat production. This model not only guarantees the quality of hogs and supply stability from the source, but also effectively hedges against the risks of cyclical fluctuations in the industry through the integration of upstream and downstream industrial chain resources. It has built an inimitable competitive barrier, providing solid support for the Company’s sustained profitability and steady development.At the same time, Muyuan Foods has continuously optimised its operational efficiency by relying on its smart hog farming system, which serves as a core driver for cost reduction and efficiency enhancement. By digitising the Company’s decades of professional hog farming knowledge through intelligent solutions, Muyuan Foods has maintained an industry-leading level in its average annual full cost. Between 2019 and 2024, its cost remained among the lowest of large-scale domestic hog farming enterprises for consecutive years. Furthermore, in the nine months ended 30 September 2025, its cost further decreased to RMB12.19 per kilogram, significantly outperforming the industry average and highlighting its exceptional cost management capabilities.Benefiting from its cutting-edge technologies and superior cost management capabilities, Muyuan Foods has achieved sustained and robust performance growth. From 2014 to 2024, the Company achieved industry-leading revenue growth with a CAGR of 48.7%, representing the highest growth rate among the top ten global listed pork companies by hog sales volume, with a significant lead. During the same period, the Company’s net profit increased at a CAGR of 72.7% and its average annual net profit margin reached 19.0%. Muyuan Foods was the only company to sustain an average annual net profit margin of above 15.0% from 2014 to 2024 among the top ten global listed pork companies, highlighting its outstanding profitability.ESG Performance Recognized by Authoritative Institutions, with Vast Market Offering Ample Space for GrowthAs a pioneer in the green transformation of the industry, Muyuan Foods has consistently and deeply integrated ESG practices into its corporate development strategy. It actively promotes industry best practices to foster the sustainable development of the hog farming industry. The Company implements comprehensive strategies to reduce emissions. Pioneering in adopting renewable energy in China’s hog farming industry, it commenced to use as early as in 2018, replacing traditional energy sources with clean energy to reduce carbon emissions in the production process. Additionally, its proprietary hog houses with fossil fuel-free heating minimize greenhouse gas emissions through precise environmental control, embodying the concept of green farming.Furthermore, Muyuan remains committed to creating lasting social value, contributing to rural revitalization and sustainable agricultural development. The Company vigorously promotes the "integrated crop-livestock cycle" model, transforming farming waste into organic fertilizer. In 2024 alone, it provided high-quality fertilizer support for approximately 4.7 million mu of farmland, conducted 9,293 agricultural technical services, covered 14,482 villages, and directly generated approximately RMB1.4 billion in economic benefits for farmers. By the end of 2024, the Company had cumulatively donated RMB107 million for public welfare projects such as road construction and streetlight installation, achieving a multi-stakeholder win-win outcome of "reducing farming waste, enhancing agricultural efficiency, and revitalizing rural areas".This exceptional ESG performance has gained recognition from authoritative institutions. As of the latest practicable date, according to the latest ESG score from the London Stock Exchange Group (LSEG), Muyuan Foods ranks among the top 20% of 504 global food and tobacco companies. Its emissions score is notably high at 90 out of 100, demonstrating robust environmental management capabilities. Significantly, the Company stands out as a hog farming enterprise within LSEG's top 100 food and tobacco companies for data and analytics, fully showcasing its ESG leadership among global peers.Regarding industry prospects, the global pork consumption market maintains steady growth. According to Frost & Sullivan, global pork consumption increased from 95.20 million tons in 2020 to 115.30 million tons in 2024, achieving a CAGR of 4.9%, indicating strong market demand resilience. As the world's largest pork consumer, China still possesses significant growth potential. In 2024, China's per capita meat consumption was 69.4 kg, compared to 102.0 kg per person in the United States, highlighting considerable room for growth. This offers ample development space for industry leaders like Muyuan Foods.With its leading technological advantages, exceptional cost-control capabilities, advanced ESG practices, and vertically integrated business model across the entire industry chain, Muyuan Foods possesses strong core competitiveness and sustainable development potential. Following the listing in Hong Kong, the Company will further broaden its international financing channels, enhance its global brand influence, accelerate global expansion and scale growth, and continue to lead the industry towards high-quality development. Its long-term growth prospects are worthy of high market expectations. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
TSUKUBA, Japan, Feb 2, 2026 - (ACN Newswire via SeaPRwire.com) - Modern industry relies heavily on catalysts, which are substances that speed up chemical reactions. They’re vital in everything from manufacturing household chemicals to generating clean energy or recycling waste. However, designing new catalysts is challenging because their performance is affected by many interacting factors.A new tool uses a catalyst gene profiling, where catalysts are represented as symbolic sequences, making it easier for scientists to interpret data and design catalysts without a need for programming skills.A new tool developed by researchers at Hokkaido University, published in Science and Technology of Advanced Materials: Methods, will simplify the process by providing researchers with a way to easily view and explore data about catalysts, enabling them to identify patterns and relationships in catalyst datasets without needing advanced programming or computational skills.The tool takes advantage of an approach known as catalyst gene profiling, where catalysts are represented as symbolic sequences. This makes it easier for scientists to interpret the data and apply sequence-based analysis methods to design and improve catalysts. The tool itself is a web-based graphical interface that offers an intuitive and interactive way to investigate these catalyst profiles.“The system enables researchers to explore complex catalyst datasets, identify global trends, and recognize local features—all without requiring advanced programming skills,” explains Professor Keisuke Takahashi, who led the study. “By visualizing both the relationships among catalysts and the underlying gene-based features, the platform makes catalyst design more interpretable, accessible, and efficient, bridging the gap between data-driven analysis and practical experimental insight.”Users can view catalysts clustered together based on how similar their features are or how similar their sequences are. The tool also includes a heat map that offers insights into how the catalyst gene sequences are calculated. The different visualizations can be viewed side by side and are synchronized so they all update simultaneously when a user zooms in or selects a group of catalysts.The team plans to extend the tool to work with other material science datasets so it can be used more broadly in the field. They’re also working to include a predictive component. Integrating modeling and editing strategies would mean researchers could use the tool not only to explore existing catalysts but also to investigate new ideas for high-performance materials. In addition, they want to improve the tool’s collaborative features so that several researchers can work together to explore and annotate datasets, enabling a community-oriented, data-driven approach to material design and discovery.“Our goal is to make advanced materials research more intuitive, approachable, and impactful,” says Takahashi.Further informationKeisuke TakahashiHokkaido University keisuke.takahashi@sci.hokudai.ac.jpPaper: https://doi.org/10.1080/27660400.2025.2600689 About Science and Technology of Advanced Materials: Methods (STAM-M)STAM Methods is an open access sister journal of Science and Technology of Advanced Materials (STAM), and focuses on emergent methods and tools for improving and/or accelerating materials developments, such as methodology, apparatus, instrumentation, modeling, high-through put data collection, materials/process informatics, databases, and programming. https://www.tandfonline.com/STAM-MDr Kazuya SaitoSTAM Methods Publishing Director SAITO.Kazuya@nims.go.jpPress release distributed by Asia Research News for Science and Technology of Advanced Materials. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
NEW YORK, Feb 1, 2026 - (ACN Newswire via SeaPRwire.com) - TCG.Zone (The Collectors Grid), a key player in the global collectibles infrastructure and ecosystem, has officially unveiled its strategic shift toward prioritizing investments in high-value, rare collectible assets. This strategic realignment underscores the company’s commitment to tapping into the long-term value and cultural significance of elite collectibles, with the recent participation in a high-profile international auction serving as a pivotal first step in this new direction.Recently, the world's only Pokémon card graded PSA 10 - Pikachu Illustrator - once again became a focal point of global attention across the collectibles and cultural landscape. As a long-term contributor to TCG infrastructure and the broader collectibles ecosystem, The Collectors Grid(TCG.Zone) participated in and witnessed this historically significant moment.Recognized as one of the most iconic works in Pokémon card history, Pikachu Illustrator is distinguished not only by its extreme rarity, but also by its symbolic representation of Pokémon culture, artistic value, and generational memory.The Legendary Status of the World's Only PSA 10According to publicly available information, the world's only PSA 10 "Pikachu Illustrator" card is currently owned by Logan Paul. The card was involved in a high-profile transaction in 2022, valued at nearly USD 5.3 million, marking a defining milestone in the history of Pokémon card collecting.The Industry Significance of Goldin AuctionsAlthough Logan Paul's acquisition of the card did not take place through Goldin, the Goldin auction platform has continued to play an important role in the card's contemporary circulation and visibility. As one of the world's most influential high-end collectibles auction platforms, Goldin's auction framework and the attention it generates brought renewed global focus to this legendary card, further positioning Pokémon cards within the broader mainstream collectibles market.Netflix Documentary Captures a Cultural MomentAmid the phenomenon-level attention generated by this card on the Goldin platform, Netflix documented the full auction process and produced a dedicated documentary. Approached from a cultural and historical perspective, the documentary highlights the unique position of Pikachu Illustrator within the modern collectibles ecosystem, elevating it beyond price alone and framing it as a lasting cultural reference.Global Participation and TCG.Zone's InvolvementThe discussions and auction activity surrounding Pikachu Illustrator attracted participation from top collectors, institutions, and professional teams from around the world. TCG.Zone was among the active participants in the bidding process. During the auction, TCG.Zone submitted a bid of USD 5,000,000. Although the bid was ultimately surpassed by a higher offer, TCG.Zone remained deeply engaged throughout the process and witnessed this pivotal moment firsthand.Continuing to Follow the Card's Future TrajectoryIn post-auction interviews, TCG.Zone stated that this participation does not mark an endpoint. The team will continue to closely monitor the movement and future trajectory of the world's only PSA 10 Pikachu Illustrator, and does not rule out participating again should the right opportunity arise. This event represents more than an auction. It stands as a collective reflection on rarity, cultural identity, and long-term value.The story of Pikachu Illustrator continues to unfold,and remains an enduring chapter in the global history of Pokémon card collecting.About TCGThe Collectors Grid is an on-chain infrastructure designed to formalize collectibles as a structured asset class. By integrating provenance, ownership, pricing, and settlement at the protocol level, it addresses long-standing inefficiencies in the global collectibles market. The platform enables institutional-grade transparency while preserving the unique characteristics of collectible assets. Positioned as a settlement layer rather than a marketplace, The Collectors Grid provides the foundational rails for liquidity, valuation, and long-term capital participation in cards, IP, and high-value collectibles.Social LinksTwitter: https://x.com/tcgzoneofficialInstagram: https://www.instagram.com/tcgzoneofficial/Telegram: https://t.me/tcgzoneofficialMedia ContactBrand : The Collectors Grid (tcg.zone)Contact: AnnieWebsite: https://www.tcg.zone Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
MOSCOW, Jan 31, 2026 - (ACN Newswire via SeaPRwire.com) - Expert Dialogues were held for the first time within the Open Dialogue framework at the Russia National Centre in Moscow on 30 January. The forum focused on five major megatrends shaping global economic, technological, and social development, bringing together international experts to explore how these forces will influence societies and industries in the decades ahead.Organized by the Russia National Centre in partnership with the Centre for Cross-Industry Expertise "The Third Rome" and supported by the Presidential Executive Office, the forum brought together experts from around the world to discuss economic, technological, and social transformations.Maksim Oreshkin, Deputy Head of the Russian Executive Administration for Global Trends, presented five key megatrends that, he said, are already shaping global development and will continue to influence the world in the coming decades."By 2026, Open Dialogue has become an international platform uniting experts from across the world to discuss the future of the planet, the global economy, and society," Oreshkin said. "Understanding these processes is essential for preparing for change and leveraging it in the interests of nations and, above all, people. Today, I will focus on five key megatrends — while not treating artificial intelligence as a separate trend, because it has already become an integral part of our lives."1. A New Global Economic Paradigm: Globalisation 2.0A shift from traditional globalisation to a more decentralised system was described. BRICS+ countries now play a growing role in the global economy, technological development, and demographic trends, while the Global South is increasingly engaging in direct trade and national-currency settlements."Globalisation hasn't ended; it has changed," Oreshkin said. "Sovereignty — at state, social, and economic levels — is now the key to competitiveness. Only countries that preserve all three levels can lead in a multipolar world."China, the USA, India, and Russia are identified as major global powers, while highlighting emerging growth centres such as Indonesia and "connector countries" like the United Arab Emirates. Digital platforms and decentralised networks are also becoming independent participants in the world economy.2. Platformisation and Institutional AutomationThe second megatrend highlights the rise of platforms and automation across all sectors. Platforms and algorithms are increasingly shaping decision-making in healthcare, education, finance, trade, and beyond."Platform solutions enhance efficiency and reduce transaction costs through self-adjusting algorithms," Oreshkin said. "Countries without technological sovereignty risk becoming dependent on external platforms, which can have strategic consequences during conflicts."3. Transformation of the Global Financial SystemIt was noted that traditional financial models face mounting challenges, including rising public debt, widening inequality, and geopolitical fragmentation. Technologies such as blockchain, artificial intelligence, and digital platforms are creating alternative financial mechanisms, including decentralised finance."The traditional model of cross-border payments is under pressure. Decentralised systems and digital technologies are reshaping the financial system," he said.4. Demographic Shifts and ChallengesThe fourth megatrend concerns global population dynamics. Global fertility rates have fallen sharply, with some countries facing critical declines. By the end of the 21st century, the working-age population may shrink significantly, while the proportion of elderly people rises, placing pressure on pension systems and social services."Even in Africa, the ratio of elderly to working-age population will rise to 30%, and globally to 56%," Oreshkin explained. "Education demand will decrease, but healthcare and social service needs will grow. These interconnected trends will amplify each other."5. Human Capital Development in the Technological EraThe final megatrend focuses on human capital in a rapidly changing technological environment.Autonomous systems, digital platforms, and artificial intelligence are transforming education, work, and healthcare, while biotechnologies expand human capabilities."AI is both a challenge and an opportunity," Oreshkin said. "It allows personalized learning paths and supports teachers.Professions are changing: mid-level specialists will be in demand, and companies must retrain employees from junior positions. The social sphere will also evolve, ensuring active longevity in the new demographic era."Global PerspectiveThroughout the presentation, Oreshkin illustrated each trend with real-life examples from different continents: a manager from Asia, a farmer from Africa, and a homemaker from Eastern Europe. He highlighted that innovations in Africa could improve education and healthcare, Eastern Europe may see rising living standards and more efficient social systems, and Asia will require reskilling to meet changing labor demands."The world has entered a period of significant change in finance, demography, and other spheres. States, companies, and individuals must be prepared. Those who understand and adapt will shape the future," Oreshkin concluded.Open Dialogue on AirThis year, Open Dialogue introduced a podcast format — Open Dialogue on Air — featuring global experts discussing key trends in international development. Participants include award-winning Chinese sci-fi writer Chen Qiufan, Dr. Selina Neri of the Future Readiness Academy, Dr. Rais Hussin of EMIR Research (Malaysia), Prof. Wang Feng of UC Irvine, and global strategist Dr. Parag Khanna.First held in April 2025 at the Russia National Centre, the Open Dialogue brought together over 3,000 experts from dozens of countries. By presidential decree, it will now be held annually.Social LinksTelegram: https://t.me/gowithrussiaVK: https://vk.com/gowithrussiaOK: https://ok.ru/gowithrussiaDZen: https://dzen.ru/gowithrussiaContact for the mediaBrand: Russia National CentreContact: Media teamEmail: Pressa@russia.ru Website: https://russia.ruEssay Submission: https://dialog.russia.ru/en/ Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
SHENZHEN, Jan 30, 2026 - (ACN Newswire via SeaPRwire.com) - China Medical System Holdings Limited (“CMS” or the “Group”) is pleased to announce that its subsidiary, Dermavon Holdings Limited (“Dermavon”, an innovative pharmaceutical company specialized in skin health which is applying for a separate listing on the Main Board of The Stock Exchange of Hong Kong Limited, please refer to the announcement published by the Group on 22 April 2025 for details) received approval from the National Medical Products Administration of China (NMPA) on 30 January 2026 for the New Drug Application (NDA) of ruxolitinib phosphate cream (the “Product”) for the treatment of non-segmental vitiligo with facial involvement in children aged 12 years and older and adult patients. It is the first and only targeted drug approved in China for vitiligo, addressing a significant unmet clinical need.Ruxolitinib phosphate cream is the first and only drug approved by the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) for repigmentation in nonsegmental vitiligo[1,2]. Prior to receiving formal NDA approval, the Group benefited from the “Early and Pilot Implementation” policy granted to the Hainan Free Trade Port and Lecheng Pilot Zone (“Lecheng Pilot Zone”), the “Hong Kong and Macau Medicine and Equipment Connect” policy, and the clinically urgently needed imported drug policies of the Beijing and Tianjin Free Trade Zones, and had already initiated the pilot application of ruxolitinib phosphate cream. Currently, Boao Super Hospital has prescribed ruxolitinib phosphate cream to over 7,000 patients with non-segmental vitiligo, and more than twenty hospitals in Guangzhou, Shenzhen, Dongguan, Foshan, Zhongshan, Zhuhai, Jiangmen, Huizhou, Beijing and Tianjin have provided prescription services for the Product, demonstrating its clinical potential.The product has shown positive results in both overseas clinical studies and the real-world study in China: in two identical Phase III double-blind, randomized, placebo-controlled studies (TRuE-V1 and TRuE-V2) conducted overseas, the proportion of patients achieving the primary efficacy endpoint of at least 75% improvement in the Facial Vitiligo Area Score Index (F-VASI 75) after 24 weeks of treatment with ruxolitinib phosphate cream was 29.9% in both studies, significantly higher than the 7.5% and 12.9% in the placebo groups, respectively. Continued use up to 52 weeks showed sustained repigmentation[3]. In accordance with the relevant regulations of the Lecheng Pilot Zone's real-world data application pilot project, ruxolitinib phosphate cream underwent real-world study in China, demonstrating positive efficacy consistent with the results of overseas pivotal clinical studies. All secondary efficacy endpoints in both domestic and overseas clinical studies showed a benefit trend consistent with the primary efficacy endpoint, and the treatment effect for vitiligo continued to improve with prolonged treatment. Furthermore, according to safety monitoring data from the Lecheng Pilot Zone, no new safety event was identified, no adverse event (AE) leading to discontinuation or withdrawal of treatment occurred, and no study drug-related serious adverse event (SAE) occurred.This approval in vitiligo brings new hope for treatment to over 10 million vitiligo patients in China, addressing urgent clinical needs. At the same time, it will add to Dermavon’s product portfolio in the field of skin treatment, potentially synergizing with Dermavon’s commercialized innovative drug ILUMETRI (tildrakizumab injection), commercialized exclusive drug Hirudoid (mucopolysaccharide polysulfate cream), and a series of innovative drugs under development and dermatological skin care products, in terms of expert network and market resources, thereby potentially enhancing Dermavon's position in the field of skin health.Furthermore, the Phase III clinical trial in China of ruxolitinib phosphate cream for the treatment of mild to moderate atopic dermatitis (AD) has achieved positive results. Currently, the Group is actively advancing the NDA for ruxolitinib phosphate cream for the treatment of AD in China, which, if approved, will provide a new treatment option for a broader patient population with AD in China.About VitiligoVitiligo is a chronic autoimmune disease characterized by depigmentation of the skin, which results from the loss of pigment-producing cells known as melanocytes. It is estimated that there are approximately 10.3 million vitiligo patients in China and non-segmental vitiligo patients account for approximately 8.2 million[4]. Existing therapies, such as topical corticosteroids (TCS) and topical calcineurin inhibitors (TCIs), have clinical limitations, with adverse reactions or limited efficacy with long-term use. The NDA approval of ruxolitinib phosphate cream successfully fills the gap in targeted drug treatment for vitiligo and is of great landmark significance.More About Ruxolitinib Phosphate CreamRuxolitinib phosphate cream (Opzelura®), a novel cream formulation of the selective JAK1/JAK2 inhibitor ruxolitinib developed by Incyte, is approved for the topical treatment of nonsegmental vitiligo in adult and patients aged 12 years and older, and for the short-term and non-continuous chronic treatment of mild to moderate AD in patients aged 2 years and older without immunodeficiency in the U.S. In Europe, ruxolitinib phosphate cream is approved for the treatment of non-segmental vitiligo with facial involvement in adults and adolescents from 12 years of age.The Group, through a subsidiary of Dermavon entered into a Collaboration and License Agreement with Incyte for ruxolitinib phosphate cream on 2 December 2022, obtaining an exclusive license to develop, register and commercialize the Product in Mainland China, Hong Kong Special Administrative Region, Macau Special Administrative Region, Taiwan Region and eleven Southeast Asian countries (the “Territory”) and a non-exclusive license to manufacture the Product in the Territory. The subsidiary of Dermavon has sublicensed the relevant rights for the Product outside Mainland China to the Group (excluding Dermavon and its subsidiary).Incyte has worldwide rights for the development and commercialization of ruxolitinib phosphate cream, marketed in the United States and Europe as Opzelura®. Opzelura® and the Opzelura® logo are registered trademarks of Incyte.About CMSCMS is a platform company linking pharmaceutical innovation and commercialization with strong product lifecycle management capability, dedicated to providing competitive products and services to meet unmet medical needs.CMS focuses on the global first-in-class (FIC) and best-in-class (BIC) innovative products, and efficiently promotes the clinical research, development and commercialization of innovative products, enabling the continuous transformation of scientific research into clinical practices to benefit patients.CMS deeply engages in several specialty therapeutic fields, and has developed proven commercialization capabilities, extensive networks and expert resources, resulting in leading academic and market positions for its major marketed products. CMS continues to promote the in-depth development in its advantageous specialty fields, strengthening the competitiveness of the cardio-cerebrovascular/ gastroenterology/ ophthalmology/ skin health businesses, bringing economies of scale in specialty fields. Among them, the skin health business (Dermavon) has become a leading enterprise in its field, and is proposed to be listed independently on the SEHK. Meanwhile, CMS continuously promotes the operation and development of its integrated R&D, manufacturing and commercialization chain in Southeast Asia and the Middle East, capturing growth opportunities in emerging markets to support the high-quality and sustainable development of the Group.Reference:1. The U.S. FDA approval information can be found on the Incyte official website, as follows:https://investor.incyte.com/news-releases/news-release-details/incyte-announces-us-fda-approval-opzeluratm-ruxolitinib-cream2. The EMA approval information can be found on the Incyte official website, as follows:https://investor.incyte.com/news-releases/news-release-details/incyte-announces-european-commission-approval-opzelurar3. The clinical studies information can be found on the Opzelura® official website, as follows:https://www.opzelura.com/opzelura-prescribing-information4. China Insights Consultancy’s industrial reportCMS Disclaimer and Forward-Looking StatementsThis press release is not intended to promote any products to you and is not for advertising purposes. This press release does not recommend any drugs, medical devices and/or indications. If you want to know more about the diagnosis and treatment of specific diseases, please follow the opinions or guidance of your doctor or other medical and health professionals. Any treatment-related decisions made by healthcare professionals should be based on the patient’s specific circumstances and in accordance with the drug package insert.This press release which has been prepared by CMS does not constitute any offer or invitation to purchase or subscribe for any securities, and shall not form the basis for or be relied on in connection with any contract or binding commitment whatsoever. This press release has been prepared by CMS based on information and data which it considers reliable, but CMS makes no representation or warranty, express or implied, whatsoever, and no reliance shall be placed on, the truth, accuracy, completeness, fairness and reasonableness of the contents of this press release. Certain matters discussed in this press release may contain statements regarding the Group’s market opportunity and business prospects that are individually and collectively forward-looking statements. Such forward-looking statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and assumptions that are difficult to predict. Any forward-looking statements and projections made by third parties included in this press release are not adopted by the Group and the Company is not responsible for such third-party statements and projections.Media ContactBrand: China Medical System Holdings Ltd.Contact: CMS Investor RelationsEmail: ir@cms.net.cnWebsite: https://web.cms.net.cn/en/home/ Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
OSAKA, Japan, January 30, 2026 - (ACN Newswire via SeaPRwire.com) - SuperX AI Technology Limited (NASDAQ: SUPX) ("the Company" or "SuperX"), an emerging AI Data Center infrastructure solutions provider, today announced the official start of production at its newly established SuperX Global Supply Center in Japan. Located in Tsu City, Mie Prefecture, Japan, this facility represents SuperX’s primary supply hub. The commencement of production at this facility marks the Company's transition from engineering and preparation to scaled commercial production. Located in Japan, this center is established to serve SuperX’s global customer base.Strategic Rationale & Operational FocusSuperX selected Japan for its first supply center to integrate Japan’s established industrial capabilities with SuperX’s technical expertise. The center focuses on three pragmatic objectives:Manufacturing Quality: Leveraging Japan’s rigorous execution standards to ensure high reliability for high-performance AI servers.Production Scale: The facility is currently capable of delivering up to 20,000 AI servers annually, providing the capacity needed to fulfill immediate demand, and expandable to fulfil future global orders.Global Export: Serving as a consolidated hub for system integration and logistics, streamlining delivery to international markets.Market ProgressThe commencement of production at the SuperX Global Supply Center supports the Company’s immediate commercial execution. In January, 2026, SuperX has secured customer purchase orders with an estimated total value of USD 910 million. Separately, the Company has also entered into MOUs with several potential customers for the purchase of 5,000 units of AI servers within the next 12 months, with an estimated total order value of up to USD 2.1 billion.Globalized Support ServicesTo better support customers through AI server product deployment and post-sales services, SuperX is rolling out a standardized technical service system, including 24/7 response via a global support center based in Singapore, expert-level technical support, and end-to-end services. For domestic Japanese delivery and operations, SuperX combines a global technical team with a local spare-parts network. This enables customizable project implementation services, and tiered SLA-backed on-site maintenance options to support rapid go-live and stable operation. Executive Commentary"This is a foundational moment for SuperX," said Dr. Chenhong Huang, Chairman and CEO of SuperX. "By establishing our first SuperX Global Supply Center in Japan, we are securing the engineering discipline and quality assurance required to compete on a global stage. This facility allows us to control our production standards and deliver reliable, full-stack AI solutions to our customers worldwide."About SuperX AI Technology Limited (NASDAQ: SUPX) SuperX AI Technology Limited is an AI infrastructure solutions provider, offering a comprehensive portfolio of proprietary hardware, advanced software, and end-to-end services for AI data centers. The Company's services include advanced solution design and planning, cost-effective infrastructure product integration, and end-to-end operations and maintenance. Its core products include high-performance AI servers, 800 Volts Direct Current (800VDC) solutions, high-density liquid cooling solutions, as well as AI cloud and AI agents. Headquartered in-Singapore, the Company serves institutional clients globally, including enterprises, research institutions, and cloud and edge computing deployments. For more information, please visit:www.superx.sg Safe Harbor Statement This press release may contain forward-looking statements. In addition, from time to time, we or our representatives may make forward-looking statements orally or in writing. We base these forward-looking statements on our expectations and projections about future events, which we derive from the information currently available to us. You can identify forward-looking statements by those that are not historical in nature, particularly those that use terminology such as "may," "should," "expects," "anticipates," "contemplates," "estimates," "believes," "plans," "projected," "predicts," "potential," or "hopes" or the negative of these or similar terms. In evaluating these forward-looking statements, you should consider various factors, including: our ability to change the direction of the Company; our ability to keep pace with new technology and changing market needs; and the competitive environment of our business. These and other factors may cause our actual results to differ materially from any forward-looking statement. Forward-looking statements are only predictions. The reader is cautioned not to rely on these forward-looking statements. The forward-looking events discussed in this press release, including quantities and estimated value of orders and other statements made from time to time by us or our representatives, may not occur, and actual events and results may differ materially and are subject to risks, uncertainties, and assumptions about us. The quantities and estimated order value mentioned in the MOUsA are non-binding and subject to the execution of purchase orders and definitive agreements . Actual delivery schedules and value of AI servers may vary based on customer data center readiness and supply chain conditions. We are not obligated to publicly update or revise any forward-looking statement, whether as a result of uncertainties and assumptions, the forward-looking events discussed in this press release and other statements made from time to time by us or our representatives might not occur. Follow our social media: X.com:https://x.com/SUPERX_AI_ LinkedIn:https://www.linkedin.com/company/superx-ai Facebook:https://www.facebook.com/people/Super-X-AI-Technology-Limited/61578918040072/# Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
